1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.
    PLEASE HELP
  1. Beenthere2Hippie
    TORONTO) - Shares of Canadian medical marijuana producers Bedrocan Cannabis Corp and OrganiGram Holdings Inc jumped as they began trading on the TSX Venture exchange on Monday with investors expecting fast-growing demand in the fledgling industry.

    The companies are the first major alternatives to Tweed Marijuana Inc, which was listed in April. The offerings mean three of the 13 medical marijuana producers licensed by regulator Health Canada are now public. Investors piled into the two stocks, pushing them well above their issued prices of 85 Canadian cents per share. Both retail and institutional investors are showing strong interest in the Canadian medical marijuana industry, which the government projects will reach C$1.3 billion in a decade.

    Bedrocan shares advanced to C$1.20, while OrganiGram gained to C$1.94. More than 4 million Bedrocan shares had changed hands by early afternoon, making it the second most heavily traded stock on the venture exchange. "It speaks to the appetite out there for marijuana names with licenses," Jacob Securities analyst Khurram Malik said. "There are (now) more ways to play companies with licenses," he added. "It's a sign that things are maturing, at least in the public markets context."

    Malik expects both companies to be valued at close to C$100 million based on Monday's trading. Moncton, New Brunswick-based OrganiGram is looking to capture the Eastern Canadian and French-speaking markets. Toronto-based Bedrocan has a licensing partnership with Dutch medical marijuana producer Bedrocan BV, which currently supplies the Canadian company's product. Both companies went public through reverse takeovers, which are carried out using a shell company already listed on an exchange. They are typically faster and cheaper than traditional initial public offerings.

    PharmaCan Capital, a holding company involved with three licensed producers, and Mettrum Ltd are two other marijuana firms that are expected to go public in the coming weeks.


    Reuters/August 25, 2014

    http://www.trust.org/item/20140825165925-zqe9v/?

    Newshawk Crew

    About Author

    Beenthere2Hippie
    BT2H is a retired news editor and writer from the NYC area who, for health reasons, retired to a southern US state early, and where BT2H continues to write and to post drug-related news to DF.

Comments

  1. Laura w
    Simply amazing that medical marijuana is making money on the sales of medical marijuana
  2. Alfa
    An increase of 41% in one day is not a bad way to make money.

    I wonder how the stocks for US medical marijuana companies have gone over time.
To make a comment simply sign up and become a member!